Page 4 - Benuvia Manufacturing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benuvia manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benuvia Manufacturing Today - Breaking & Trending Today

Benuvia Manufacturing Appoints Scott Aladeen as Chief Operating Officer

/PRNewswire/ Benuvia Manufacturing, Inc., a leading contract development and manufacturing organization (CDMO), today announced the appointment of K. Scott. ....

Quva Pharma , Benuvia Manufacturing Inc , Boehringer Ingelheim , Avara Pharmaceutical Services , Astellas Pharma , Benuvia Manufacturing ,

Benuvia Manufacturing Appoints Scott Aladeen as Chief Operating Officer

/PRNewswire/ Benuvia Manufacturing, Inc., a leading contract development and manufacturing organization (CDMO), today announced the appointment of K. Scott. ....

Quva Pharma , Benuvia Manufacturing Inc , Boehringer Ingelheim , Avara Pharmaceutical Services , Astellas Pharma , Benuvia Manufacturing ,

Benuvia Manufacturing Institutes Senior Advisory Board

Benuvia Manufacturing Institutes Senior Advisory Board
Valeria Coscia, Ph.D. , Bill DuBay, Ph.D., Paul Evans, and Mike Wittmann, Ph.D. will strategically advise Benuvia Manufacturing, a growing, privately held company
News provided by
Share this article
Share this article
ROUND ROCK, Texas, Jan. 14, 2021 /PRNewswire/ Benuvia Manufacturing, Inc, a leading CDMO providing small molecule active pharmaceutical ingredients, formulation and drug product manufacturing from preclinical to commercial scale, today announced the formation and appointment of a Senior Advisory Board. The members of the Senior Advisory Board bring more than 80 years of pharmaceutical and business experience.
Valeria Coscia, Ph.D., Bill DuBay, Ph.D., Paul Evans and Mike Wittmann, Ph.D. bring a wide variety of expertise and talent to this inaugural board. ....

United States , Round Rock , Paul Evans , Valeria Coscia , Mike Wittmann , Johnson Matthew Teva , Bill Dubay , Scott Watson , Merchandising Department , Department Of Marketing , University Of Southern Mississippi , Noramco Inc , Drug Administration , Benuvia Manufacturing Leadership Team , University Of Alabama At Birmingham , Pharmascience Inc , Benuvia Manufacturing Inc , Collat School Of Business , Qualitest Pharmaceuticals , Global Business Development , Alita Pharmaceuticals , Benuvia Manufacturing , Senior Advisory , Senior Advisory Board , Chief Technology Officer , Vice President Global Business Development ,

Radius Health, Inc. Announces Acquisition of Orphan Disease Program

Published: Jan 06, 2021
RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases
Prader-Willi syndrome (“PWS”) will be the initial indication, which has been granted Orphan Drug and Fast Track Designation by the FDA
Acquisition and associated PWS trial costs to be funded from existing operations
Management to host conference call and webcast this morning at 8:15 a.m. ET
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE)
Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced a definitive agreement to acquire the global development and commercialization rights to
Benuvia Therapeutics Inc.’s (“Benuvia”) synthetic cannabidiol oral solution (“RAD011”). The Company plans to initiate a pivotal Phase 2/3 study for patients with Prader-Willi syndrome (“PWS”) in the second half of 2021 pending regulatory discussion with the U.S. ....

United States , Peter Schwartzman , Kelly Martin , Julie Ferguson , Toddc Davis , Benuvia Therapeutics Inc , Company Nasdaq , Jp Morgan Securities , Foundation For Prader Willi Research , Drug Administration , Research Development , Ropes Gray , Exchange Commission , Radius Health , Radius Health Inc , Orphan Drug , Fast Track Designation , Benuvia Therapeutics , Radius Chief Executive Officer , Benuvia Manufacturing , Rady Children , Prader Willi Syndrome Clinic , Prader Willi Research , Orphan Drug Designation , Private Securities Litigation Reform Act , Annual Report ,